This company seems to have been delisted
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Bellerophon Therapeutics
BLPH
$0.01200
Share price
-36.84%
Change (1 day)
-80.00%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Net assets
Net assets on the balance sheet as of September 2023 : $3.72 Million USD
According to Bellerophon Therapeutics
's latest financial reports the company has $3.72 Million USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bellerophon Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $$2.53 M | -88.28% |
| 2021-12-31 | $$21.61 M | -43.48% |
| 2020-12-31 | $$38.24 M | 965.14% |
| 2019-12-31 | $$3.59 M | -6.87% |
| 2018-12-31 | $$3.85 M | -248.65% |
| 2017-12-31 | $-$2.6 Million | -114.42% |
| 2016-12-31 | $$17.99 M | -40.69% |
| 2015-12-31 | $$30.33 M | 32.26% |
| 2014-12-31 | $$22.93 M | -245.75% |
| 2013-12-31 | $-$15.74 Million | 41.57% |
| 2012-12-31 | $-$11.12 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $7.05 B | 189,370.86% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $41.39 M | 1,011.90% | 🇺🇸 USA |
 Abbott Laboratories ABT | $49.06 B | 1,317,761.94% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $1.16 B | 31,170.21% | 🇺🇸 USA |